Global Cancer Drug Therapy Market Insights, Forecast to 2025

  • TBI882456
  • August 28, 2018
  • Global
  • 121 pages
  • QY Research
                                              This report studies the global market size of Cancer Drug Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cancer Drug Therapy in these regions.
This research report categorizes the global Cancer Drug Therapy market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Kidney cancer or renal cancer is one of the ten most frequently diagnosed cancers, found mainly in people aged 60 or above. According to the estimates of the American Cancer Society (ACS), 61,560 new kidney cancer cases and 14,080 deaths would occur in 2015. Due to the increasing prevalence with no cure of this deadly disease, till date, there is an imminent need for effective kidney cancer drugs.

The renal cancer drug therapy market has witnessed a dramatic change in its treatment paradigm over the last three decades. Although, there are a variety of treatment options available, innovators have now shifted their focus towards more targeted therapies and immunotherapies. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors boosting the growth of the market. Strong pipeline and fast-emerging treatments are expected to further boost the market during the analysis period. However, high cost of drugs, looming off-patents and uncertain reimbursement policies are some of the factors that are likely to restrain the market growth.

Winning a physicians confidence regarding the cost, efficacy and dosage would lead to a higher acceptance of drugs in the market. Additionally, immunotherapies would emerge as an opportunity for innovators in the kidney cancer drugs market. Furthermore, untapped geographies with a high undiagnosed patient base would offer lucrative opportunities for the innovators in future. However, overcoming the generic drugs competition would be a key challenge for the leading innovators.
In 2017, the global Cancer Drug Therapy market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Cancer Drug Therapy market based on company, product type, application and key regions.

The various contributors involved in the value chain of Cancer Drug Therapy include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Cancer Drug Therapy include
    Amgen / Allergan
    Argos Therapeutics
    Aveo Pharmaceuticals
    Bristol-Myers Squibb
    Genentech (Roche)
    Prometheus Labs

Market Size Split by Type
    Targeted Therapy
Market Size Split by Application
    Angiogenesis Inhibitors
    mTOR Inhibitors
    Monoclonal Antibodies
    Cytokine Immunotherapy (IL-2)

Market size split by Region
    North America
        United States
        South Korea
    Central & South America
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        South Africa

The study objectives of this report are:
    To study and analyze the global Cancer Drug Therapy market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Cancer Drug Therapy market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Cancer Drug Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Cancer Drug Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Cancer Drug Therapy submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Cancer Drug Therapy are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cancer Drug Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
    1.1  Cancer Drug Therapy Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Cancer Drug Therapy Market Size Growth Rate by Type
        1.4.2 Targeted Therapy
        1.4.3 Chemotherapy
        1.4.4 Immunotherapy
    1.5 Market by Application
        1.5.1 Global Cancer Drug Therapy Market Size Growth Rate by Application
        1.5.2 Angiogenesis Inhibitors
        1.5.3 mTOR Inhibitors
        1.5.4 Monoclonal Antibodies
        1.5.5 Cytokine Immunotherapy (IL-2)
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Cancer Drug Therapy Market Size
        2.1.1 Global Cancer Drug Therapy Revenue 2016-2025
        2.1.2 Global Cancer Drug Therapy Sales 2016-2025
    2.2 Cancer Drug Therapy Growth Rate by Regions
        2.2.1 Global Cancer Drug Therapy Sales by Regions
        2.2.2 Global Cancer Drug Therapy Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Cancer Drug Therapy Sales by Manufacturers
        3.1.1 Cancer Drug Therapy Sales by Manufacturers
        3.1.2 Cancer Drug Therapy Sales Market Share by Manufacturers
        3.1.3 Global Cancer Drug Therapy Market Concentration Ratio (CR5 and HHI)
    3.2 Cancer Drug Therapy Revenue by Manufacturers
        3.2.1 Cancer Drug Therapy Revenue by Manufacturers (2016-2018)
        3.2.2 Cancer Drug Therapy Revenue Share by Manufacturers (2016-2018)
    3.3 Cancer Drug Therapy Price by Manufacturers
    3.4 Cancer Drug Therapy Manufacturing Base Distribution, Product Types
        3.4.1 Cancer Drug Therapy Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Cancer Drug Therapy Product Category
        3.4.3 Date of International Manufacturers Enter into Cancer Drug Therapy  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Cancer Drug Therapy Sales by Type
    4.2 Global Cancer Drug Therapy Revenue by Type
| 

Request a sample

Fill below form to request a sample


Please fill this form to enquire before buying


You can request for discount regarding the report by using below form